Cover ImageSALE
市場調查報告書

全球性傳染病檢查(STD檢驗)市場(2018年∼2022年)

Global Sexually Transmitted Diseases Testing Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 317317
出版日期 內容資訊 英文 109 Pages
訂單完成後即時交付
價格
Back to Top
全球性傳染病檢查(STD檢驗)市場(2018年∼2022年) Global Sexually Transmitted Diseases Testing Market 2018-2022
出版日期: 2018年01月12日 內容資訊: 英文 109 Pages
簡介

關於全球性傳染病檢查(STD檢驗)

性感染疾病(STD)稱為STI,是透過性行為傳播的細菌、霉、寄生蟲、病毒造成的感染疾病,產生STD檢驗的必要性和需求。

Technavio的分析師預測,從2018年到2022年之間,性傳染病檢查(STD檢驗)市場將以8.61%的年複合成長率成長。

本報告提供性傳染病檢查(STD檢驗)的全球市場調查,市場概要,各檢查裝置、地區的市場趨勢,市場規模的變化與預測,推動市場要素及課題分析,競爭情形,主要企業的簡介等全面的資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生命週期
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 全球STD檢驗市場:概要
  • 市場規模
  • 全球STD檢驗市場

第6章 波特的五力分析

  • 買方議價能力
  • 供給企業談判力
  • 新加入業者的威脅
  • 替代品的威脅
  • 競爭企業間的敵對關係

第7章 市場區隔:各檢查裝置

  • 全球STD檢驗市場:各檢查裝置
  • 比較:各檢查裝置
  • 實驗室檢查裝置
  • POC實驗設備
  • 市場機會:各檢查裝置

第8章 客戶形勢

第9章 地區形勢

  • 地理市場區隔
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 市場機會

第10章 決策架構

第11章 成長要素與課題

  • 市場成長要素
  • 市場課題

第12章 市場趨勢

  • POC實驗的需求增加
  • HIV相關意識的提高
  • 啟發活動的重要性增加

第13章 業者情勢

  • 概要
  • 創造性破壞

第14章 供應商分析

  • 交易廠商
  • 供應商的分類
  • 供應商的市場定位
  • Abbott
  • bioMerieux
  • Bio-Rad Laboratories
  • F. Hoffmann La Roche
  • 其他有力的供應商
  • 概要

第15章 附錄

  • 簡稱的清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR20101

About Sexually Transmitted Diseases Testing

STDs, also known as STIs, are infectious diseases caused by bacteria, yeast, parasites, and viruses, and are transmitted through sexual contact, thus generating the need for STD testing and demand for devices used for testing.

Technavio's analysts forecast the global sexually transmitted diseases testing market to grow at a CAGR of 8.61% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global sexually transmitted diseases testing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Sexually Transmitted Diseases Testing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • bioMerieux
  • Bio-Rad Laboratories
  • F. Hoffmann La Roche

Market driver

  • Rise in STDs
  • For a full, detailed list, view our report

Market challenge

  • Lack of trained professionals
  • For a full, detailed list, view our report

Market trend

  • High demand for POC testing
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Global STD testing market overview
  • Market sizing 2017
  • Global STD testing market

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY TESTING DEVICES

  • Global STD testing market by testing devices
  • Comparison by testing devices
  • Global STD testing market by laboratory testing devices
  • Global STD testing market by POC testing devices
  • Market opportunity by testing devices

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • STD testing market in Americas
  • STD testing market in EMEA
  • STD testing market in APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • High demand for POC testing
  • Rising awareness regarding HIV
  • Increasing importance of promotional activities

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • bioMerieux
  • Bio-Rad Laboratories
  • F. Hoffmann La Roche
  • Other prominent vendors
  • Company
  • Description

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Related market
  • Exhibit 02: Market characteristics
  • Exhibit 03: Market segments
  • Exhibit 04: Market definition: Inclusions and exclusions checklist
  • Exhibit 05: Validation techniques employed for market sizing 2017
  • Exhibit 06: Global STD testing market 2017-2022 ($ billions)
  • Exhibit 07: Global STD testing market: Year-over-year (YoY) growth 2018-2022 (%)
  • Exhibit 08: Five forces analysis 2017
  • Exhibit 09: Five forces analysis 2022
  • Exhibit 10: Bargaining power of buyers
  • Exhibit 11: Bargaining power of suppliers
  • Exhibit 12: Threat of new entrants
  • Exhibit 13: Threat of substitutes
  • Exhibit 14: Threat of rivalry
  • Exhibit 15: Market condition: Five forces 2017
  • Exhibit 16: Market condition: Five forces 2022
  • Exhibit 17: Global STD testing market by testing devices 2017-2022 (%)
  • Exhibit 18: Comparison by testing devices
  • Exhibit 19: Global STD testing market by laboratory testing devices 2017-2022 ($ billions)
  • Exhibit 20: Global STD testing market by laboratory testing devices: YoY growth 2018-2022 (%)
  • Exhibit 21: Global STD testing market by POC testing devices 2017-2022 ($ billions)
  • Exhibit 22: Global STD testing market by POC testing devices: YoY growth 2018-2022 (%)
  • Exhibit 23: Market opportunity by testing devices
  • Exhibit 24: Customer landscape
  • Exhibit 25: Global STD testing market by geography 2017-2022 (%)
  • Exhibit 26: Regional comparison
  • Exhibit 27: STD testing market in Americas 2017-2022 ($ billions)
  • Exhibit 28: Americas: YoY growth 2018-2022 (%)
  • Exhibit 29: Top three countries in Americas
  • Exhibit 30: STD testing market in EMEA 2017-2022 ($ billions)
  • Exhibit 31: STD testing market in EMEA: YoY growth 2018-2022 (%)
  • Exhibit 32: Top three countries in EMEA
  • Exhibit 33: STD testing market in APAC 2017-2022 ($ billions)
  • Exhibit 34: STD testing market in APAC: YoY growth 2018-2022 (%)
  • Exhibit 35: Top three countries in APAC
  • Exhibit 36: Market opportunity
  • Exhibit 37: Vendor landscape
  • Exhibit 38: Landscape disruption
  • Exhibit 39: Vendors covered
  • Exhibit 40: Vendor classification
  • Exhibit 41: Market positioning of vendors
  • Exhibit 42: Vendor overview
  • Exhibit 43: Abbott: Business segments
  • Exhibit 44: Abbott: Organizational developments
  • Exhibit 45: Abbott: Geographic focus
  • Exhibit 46: Abbott: Segment focus
  • Exhibit 47: Abbott: Key offerings
  • Exhibit 48: Vendor overview
  • Exhibit 49: bioMerieux: Business segments
  • Exhibit 50: bioMerieux: Organizational developments
  • Exhibit 51: bioMerieux: Geographic focus
  • Exhibit 52: bioMerieux: Segment focus
  • Exhibit 53: bioMerieux: Key offerings
  • Exhibit 54: Vendor overview
  • Exhibit 55: Bio-Rad laboratories: Business segments
  • Exhibit 56: Bio-Rad laboratories: Organizational developments
  • Exhibit 57: Bio-Rad Laboratories: Geographic focus
  • Exhibit 58: Bio-Rad Laboratories: Segment focus
  • Exhibit 59: Bio-Rad laboratories: Key offerings
  • Exhibit 60: Vendor overview
  • Exhibit 61: F. Hoffmann La Roche: Business segments
  • Exhibit 62: F. Hoffmann La Roche: Organizational developments
  • Exhibit 63: F. Hoffmann La Roche: Geographic focus
  • Exhibit 64: F. Hoffmann La Roche: Segment focus
  • Exhibit 65: F. Hoffmann La Roche: Key offerings
Back to Top